137 related articles for article (PubMed ID: 12460413)
1. Improvements in artery occlusion by low-density lipoprotein apheresis in a patient with peripheral arterial disease.
Kamimura M; Matsuo M; Miyahara T; Kimura K; Matsumoto K; Nakaya T; Abe T; Akizawa T
Ther Apher; 2002 Dec; 6(6):467-70. PubMed ID: 12460413
[TBL] [Abstract][Full Text] [Related]
2. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
[TBL] [Abstract][Full Text] [Related]
3. Effect of low-density lipoprotein apheresis on plasma endothelin-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
Nakamura T; Ushiyama C; Osada S; Inoue T; Shimada N; Koide H
J Diabetes Complications; 2003; 17(6):349-54. PubMed ID: 14583180
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of low-density lipoprotein apheresis in arteriosclerosis obliterans of the lower extremities: two cases with marked alleviation of clinical symptoms.
Suzuki T; Sato Y; Niizuma S; Kushiro T; Tani S; Ishikawa K; Kajiwara N; Kanmatsuse K; Ikeda H; Takahashi M; Kojima S
J Clin Apher; 2007; 22(5):287-91. PubMed ID: 17610290
[TBL] [Abstract][Full Text] [Related]
5. Effects of LDL apheresis and vitamin E-modified membrane on carotid atherosclerosis in hemodialyzed patients with arteriosclerosis obliterans.
Nakamura T; Kawagoe Y; Matsuda T; Takahashi Y; Sekizuka K; Ebihara I; Koide H
Kidney Blood Press Res; 2003; 26(3):185-91. PubMed ID: 12886046
[TBL] [Abstract][Full Text] [Related]
6. LDL apheresis in atherosclerotic disease with hyperlipidemia.
Naganuma S; Agishi T; Ota K
ASAIO J; 1992; 38(3):M436-9. PubMed ID: 1457897
[TBL] [Abstract][Full Text] [Related]
7. Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study.
Nakajima F; Morimoto S; Yurugi T; Amari Y; Kasuno Y; Fukui M; Furumatsu Y; Kitamura T
Int J Artif Organs; 2012 Nov; 35(11):981-5. PubMed ID: 23065872
[TBL] [Abstract][Full Text] [Related]
8. Improvement of peripheral circulation by low density lipoprotein adsorption.
Agishi T; Kitano Y; Suzuki T; Miura A; Murakami J; Minagawa H; Ban K
ASAIO Trans; 1989; 35(3):349-51. PubMed ID: 2597479
[TBL] [Abstract][Full Text] [Related]
9. Combination treatment using percutaneous transluminal angioplasty and low-density lipoprotein apheresis in a patient with peripheral arterial disease and a history of chronic hemodialysis.
Nishimura H; Enokida H; Tsuruta M; Yoshino Y; Yamada Y; Sugita S; Hayashi S; Arata K; Hayami H; Nishiyama K; Nakagawa M
J Clin Apher; 2013 Aug; 28(4):330-4. PubMed ID: 23450792
[TBL] [Abstract][Full Text] [Related]
10. LDL apheresis for arteriosclerosis obliterans with occluded bypass graft: change in prostacyclin and effect on ischemic symptoms.
Mii S; Mori A; Sakata H; Nakayama M; Tsuruta H
Angiology; 1998 Mar; 49(3):175-80. PubMed ID: 9523539
[TBL] [Abstract][Full Text] [Related]
11. Current status of low-density lipoprotein apheresis treatment for patients with peripheral artery disease and chronic kidney disease in Japanese clinical database.
Watanabe Y; Tanaka A; Furuhashi K; Maruyama S
Ther Apher Dial; 2023 Dec; 27(6):1000-1009. PubMed ID: 37587685
[TBL] [Abstract][Full Text] [Related]
12. Analysis of protein absorbed by LDL column (Liposorber) with special reference to complement component factor D.
Oda O; Nagaya T; Ogawa H
Clin Chim Acta; 2004 Apr; 342(1-2):155-60. PubMed ID: 15026276
[TBL] [Abstract][Full Text] [Related]
13. Minimal impact of low-density lipoprotein apheresis on vancomycin serum concentration: A case report.
Hiyama Y; Tomita T; Matsuo H
J Infect Chemother; 2024 Aug; 30(8):812-814. PubMed ID: 38316186
[TBL] [Abstract][Full Text] [Related]
14. Marked removal of bezafibrate-induced high-density lipoprotein-cholesterol by low-density lipoprotein apheresis.
Kawano M; Kuroda Y; Terao M; Yaginuma T; Kawakami M; Kanazawa Y
Clin Chim Acta; 2002 Apr; 318(1-2):91-5. PubMed ID: 11880117
[TBL] [Abstract][Full Text] [Related]
15. LDL apheresis reduces the susceptibility of LDL to in vitro oxidation in a diabetic patient with hemodialysis treatment.
Inoue I; Takahashi K; Kikuchi C; Katayama S
Diabetes Care; 1996 Oct; 19(10):1103-7. PubMed ID: 8886556
[TBL] [Abstract][Full Text] [Related]
16. The role of low-density lipoprotein apheresis as postoperative care of bypass grafting for chronic arterial occlusion.
Takagi M; Yamada T; Yamaguchi H; Hashiyada H; Narimatsu M; Shibata R; Yamauchi H; Miyagawa N; Kugimiya T
Cardiovasc Surg; 1996 Aug; 4(4):459-65. PubMed ID: 8866081
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of clinical state for arteriosclerosis obliterans in lower extremity of diabetic patients on peritoneal dialysis].
Shi JB; Sun QH; Nie JD; Sun LH; Zhang N; Han QF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Feb; 45(1):109-13. PubMed ID: 23411531
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of low-density lipoprotein apheresis in patients with peripheral arterial occlusive disease undergoing hemodialysis treatment.
Morimoto S; Yano Y; Maki K; Sawada K; Iwasaka T
Am J Nephrol; 2007; 27(6):643-8. PubMed ID: 17878713
[TBL] [Abstract][Full Text] [Related]
19. Low-density lipoprotein apheresis for haemodialysis patients with peripheral arterial disease reduces reactive oxygen species production via suppression of NADPH oxidase gene expression in leucocytes.
Hara T; Kiyomoto H; Hitomi H; Moriwaki K; Ihara G; Kaifu K; Fujita Y; Higashiyama C; Nishiyama A; Kohno M
Nephrol Dial Transplant; 2009 Dec; 24(12):3818-25. PubMed ID: 19617260
[TBL] [Abstract][Full Text] [Related]
20. Low-density lipoprotein apheresis in a patient with arteriosclerosis obliterans and light chain deposition disease.
Nakamura T; Kawagoe Y; Matsuda T; Ueda Y; Koide H
Clin Nephrol; 2004 Jun; 61(6):429-33. PubMed ID: 15224807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
